Syndicated Research Studies

If you've been tracking life sciences investment or following breakthroughs in drug discovery, you've almost certainly come across the term proteomics. But what does the proteomics market actually look like right now — and is the growth story as compelling as the headlines suggest? Short answer: yes, and then some. Let's walk through it. How Big Is the Proteomics Market Today? The global proteomics market is experiencing rapid expansion, driven by technological advancements and increasing healthcare demands. Market size reached USD 27.8 billion in 2024 Expected to grow to USD 58.16 billion by 2030 Registering a strong CAGR of 12.9% (2025–2030) This kind of double-digit growth clearly signals that proteomics is no longer a niche scientific domain—it’s becoming a cornerstone of modern healthcare and biotechnology. What’s Fueling Proteomics Market Growth? Rising Demand for Personalized Medicine Healthcare is shifting from “one-size-fits-all...

Proteomics Market Overview The global proteomics market was valued at USD 27.8 billion in 2024 and is expected to expand to USD 58.16 billion by 2030, registering a robust CAGR of 12.9% from 2025 to 2030. Market growth is primarily supported by the increasing prevalence of chronic and infectious diseases, rising demand for rapid and advanced diagnostic solutions, and the growing adoption of personalized medicine in disease management and treatment planning. Continuous technological progress in protein analysis techniques is further accelerating market expansion. The increasing global disease burden has intensified the need for in-depth pathogenesis research, as well as the development of advanced diagnostics and targeted therapeutics. According to projections by the World Health Organization, global cancer incidence is expected to exceed 35 million new cases by 2050, representing a 77% increase compared to the approximately 20 million cases reported in 2022. This rising disease prev...

Proteomics Market Summary The global proteomics market was valued at USD 27.8 billion in 2024 and is expected to reach USD 58.16 billion by 2030, expanding at a CAGR of 12.9% from 2025 to 2030. Market growth is fueled by the increasing prevalence of chronic and infectious diseases, rising demand for rapid and advanced diagnostic tools, and the expanding adoption of personalized medicine. Technological progress in protein analysis continues to support industry expansion. With chronic and infectious diseases on the rise, the need for proteomics-based research and diagnostics is growing. The WHO projects more than 35 million new cancer cases by 2050, marking a 77% increase from the estimated 20 million cases in 2022, which further emphasizes the importance of advanced disease research. Recent studies underscore the growing relevance of proteomics. For example, research published in Nature Communications in July 2024 utilized a proteomics-driven method to identify effectors secreted by...

Proteomics Market Growth & Trends The global proteomics market size is expected to reach USD 58.16 billion by 2030, registering a CAGR of 13.10% from 2024 to 2030, according to a new report by Grand View Research, Inc. The major factors driving the industry growth are a rise in the demand for personalized medicine, an expansion of the pipeline of diagnostics utilizing proteomics mass spectrometry as well as biochip platforms, and discoveries based on genomics. Moreover, owing to the importance of proteomics in drug development, numerous pharmaceutical companies have established their own proteomic divisions, which are fueling the expansion of the global industry. For instance, in September 2021, Biognosys, announced the collaboration with Evotec, to promote the use of next-generation proteomics in clinical research and drug discovery. The COVID-19 outbreak is expected to have a significant impact on the industry, as researchers across the world are concentratin...